Sign In

Login

Password

Forgot Password ? Sign Up

Nepafenak (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nepafenak" in Serbian language version.

refsWebsite
Global rank Serbian rank
10doi.org
2nd place
4th place
9nih.gov
4th place
8th place
1hc-sc.gc.ca
low place
low place
1harvard.edu
18th place
28th place

doi.org

  • Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Gamache, D. A.; Graff, G.; Brady, M. T.; Spellman, J. M.; Yanni, J. M. (2000 Aug). „Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy”. Inflammation. 24 (4): 357—70. PMID 10850857. doi:10.1023/a:1007049015148.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Ke TL, Graff G, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Ke, T. L.; Graff, G.; Spellman, J. M.; Yanni, J. M. (2000 Aug). „Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers”. Inflammation. 24 (4): 371—84. PMID 10850858. doi:10.1023/a:1007001131987.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Lane SS, Modi SS, Lehmann RP, Holland EJ: Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Lane, S. S.; Modi, S. S.; Lehmann, R. P.; Holland, E. J. (2007 Jan). „Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery”. J Cataract Refract Surg. 33 (1): 53—8. PMID 17189793. doi:10.1016/j.jcrs.2006.08.043.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. Walters, T.; Raizman, M.; Ernest, P.; Gayton, J.; Lehmann, R. (2007 Sep). „In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac”. J Cataract Refract Surg. 33 (9): 1539—45. PMID 17720067. doi:10.1016/j.jcrs.2007.05.015.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Bucci FA Jr, Waterbury LD: Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. Bucci Jr, F. A.; Waterbury, L. D. (2008 Aug). „Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac”. Journal of Cataract and Refractive Surgery. 34 (8): 1226; author reply 1226—7. PMID 18655957. doi:10.1016/j.jcrs.2008.05.019.  Проверите вредност парамет(а)ра за датум: |date= (помоћ); author reply 1226-7.
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 
  • Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e. 

harvard.edu

adsabs.harvard.edu

  • Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o. 

hc-sc.gc.ca

nih.gov

ncbi.nlm.nih.gov

  • Gamache DA, Graff G, Brady MT, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy. Gamache, D. A.; Graff, G.; Brady, M. T.; Spellman, J. M.; Yanni, J. M. (2000 Aug). „Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacy”. Inflammation. 24 (4): 357—70. PMID 10850857. doi:10.1023/a:1007049015148.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Ke TL, Graff G, Spellman JM, Yanni JM: Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers. Ke, T. L.; Graff, G.; Spellman, J. M.; Yanni, J. M. (2000 Aug). „Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers”. Inflammation. 24 (4): 371—84. PMID 10850858. doi:10.1023/a:1007001131987.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Lane SS, Modi SS, Lehmann RP, Holland EJ: Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Lane, S. S.; Modi, S. S.; Lehmann, R. P.; Holland, E. J. (2007 Jan). „Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery”. J Cataract Refract Surg. 33 (1): 53—8. PMID 17189793. doi:10.1016/j.jcrs.2006.08.043.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Walters T, Raizman M, Ernest P, Gayton J, Lehmann R. Walters, T.; Raizman, M.; Ernest, P.; Gayton, J.; Lehmann, R. (2007 Sep). „In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac”. J Cataract Refract Surg. 33 (9): 1539—45. PMID 17720067. doi:10.1016/j.jcrs.2007.05.015.  Проверите вредност парамет(а)ра за датум: |date= (помоћ)
  • Bucci FA Jr, Waterbury LD: Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. J Cataract Refract Surg. Bucci Jr, F. A.; Waterbury, L. D. (2008 Aug). „Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac”. Journal of Cataract and Refractive Surgery. 34 (8): 1226; author reply 1226—7. PMID 18655957. doi:10.1016/j.jcrs.2008.05.019.  Проверите вредност парамет(а)ра за датум: |date= (помоћ); author reply 1226-7.
  • Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—D1041. PMC 3013709 Слободан приступ. PMID 21059682. doi:10.1093/nar/gkq1126. 
  • Wishart, David S.; Knox, Craig; Guo, An Chi; Cheng, Dean; Shrivastava, Savita; Tzur, Dan; Gautam, Bijaya; Hassanali, Murtaza (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—D906. PMC 2238889 Слободан приступ. PMID 18048412. doi:10.1093/nar/gkm958. 
  • Tetko, Igor V.; Tanchuk, Vsevolod Yu.; Kasheva, Tamara N.; Villa, Alessandro E. P. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t. 
  • Ertl, Peter; Rohde, Bernhard; Selzer, Paul (2000). „Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.